Effect of preanalytical variables on myeloperoxidase levels

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1650-1655

  Wendland, Andrea Elisabet ^a,c   Camargo, Joíza Lins ^b   Polanczyk, Carisi Anne ^b,c  

^a Central Public Health Laboratory   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cardiovascular disease; Inflammation; Myeloperoxidase; Preanalytical variables

Indexed keywords

ANTICOAGULANT AGENT; EDETIC ACID; MYELOPEROXIDASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME STABILITY; FEMALE; HEART DISEASE; HEPARINIZATION; HUMAN; MALE; PLASMA; PRIORITY JOURNAL; SERUM; STORAGE TEMPERATURE; TEMPERATURE SENSITIVITY;

EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELS; HEART DISEASES; HEPARIN; HUMANS; PEROXIDASE; PROTEIN STABILITY; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SERUM; SPECIMEN HANDLING; TEMPERATURE;

EID: 77956494821     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.06.015     Document Type: Article

References (37)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
2. Hansson G.K. Mechanisms of disease: inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Nicholls S.J., Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:1102-1111.
4. Apple F.S., Wu A.H.B., Mair J., Ravkilde J., Panteghini M., Tate J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005, 51:810-824.
5. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 106:2894-2900.
6. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 1999, 103:1547-1560.
7. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda S.E., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002, 277:46116-46122.
8. Nicholls S., Zheng L., Hazen S.L. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 2005, 15:212-219.
9. Hazen S.L. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol 2004, 24:1143-1146.
10. Sugiyama S., Kugiyama K., Aikawa M., Nakamura S., Ogawa H., Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression. Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004, 24:1309-1314.
11. Vita J.A., Brennan M.L., Gokce N., Mann S.A., Goormastic M., Shishehbor M.H., et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004, 110:1134-1139.
12. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004, 37:902-911.
13. Vasilyev N., Williams T., Brennan M.L., Unzek S., Zhou X., Heinecke J.W., et al. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 2005, 112:2812-2820.
14. Meuwese M.C., Stroes W.S., Hazen S.L., van Miert J.N., Kuivenhoven J.A., Schaub R.G., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. J Am Coll Cardiol 2007, 50:159-165.
15. Stefanescu A., Braun S., Ndrepepa G., Koppara T., Pavaci H., Mehilli J., et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 2008, 155:356-360.
16. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münzel T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
17. Cavusoglu E., Ruwende C., Eng C., Chopra V., Yanamadala S., Clark L.T., et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007, 99:1364-1368.
18. Mocatta T.J., Pilbrow A.P., Cameron V.A., Senthilmohan R., Frampton C.M., Richards A.M., et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007, 49:1993-2000.
19. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003, 349:1595-1604.
20. Tang W.H.W., Brennan M.L., Philip K., Tong W., Mann S., Van Lente F., et al. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 2006, 98:796-799.
21. Tang W.H.W., Tong W., Troughton R.W., Martin M.G., Shrestha K., Borowski A., et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 2007, 49:2364-2370.
22. Morrow D.A. Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes. J Am Coll Cardiol 2007, 49:2001-2002.
23. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 8:307-310.
24. Roman R.M., Wendland A.E., Polanczyk C.A. Myeloperoxidase and coronary arterial disease: from research to clinical practice. Arq Bras Cardiol 2007, 91:e12-e19.
25. Stiegler H., Fischer Y., Jimenez J.F.V., Graf J., Filzmaier K., Fausten B., et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000, 46:1338-1344.
26. Gerhardt W., Nordin G., Herbert A.K., Burzell B.L., Isaksson A., Gustavsson E., et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000, 46:817-821.
27. Ledue T.B., Rifai N. Preanalytic and analytic sources of variation in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003, 49:1258-1271.
28. Lippi G., Salvagno G.L., Montagnana M., Guidi G.C. Measurement of Elecsys NT-proBNP in serum, K2 EDTA and heparin plasma. Clin Biochem 2007, 40:747-748.
29. Shimizu H., Aono K., Masuta K., Asada H., Misaki A., Teraoka H. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999, 285:169-172.
30. Nowatzke W.L., Cole T.G. Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze-thaw cycles. Clin Chem 2003, 49:1560-1562.
31. Chang P.Y., Wu T.L., Hung C.C., Tsao K.C., Sun C.F., Wu L.L., et al. Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation. Clin Chim Acta 2006, 373:158-163.
32. Shih J., Datwyler S.A., Hsu S.C., Matias M.S., Pacenti D.P., Lueders C., et al. Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. Clin Chem 2008, 54:1076-1079.
33. Roberts W.L., Schwarz E.L., Ayanian S., Rifai N. Performance characteristics of a point of care C-reactive protein assay. Clin Chim Acta 2001, 314:255-259.
34. Rothkrantz-Kos S., Schmitz P.J., Bekers O., Menheere P.P.C.A., van Dieijen-Visser M.P. High-sensitivity C-reactive protein methods examined. Clin Chem 2002, 48:359-362.
35. Dasgupta A., Chow L., Tso G., Nazareno L. Stability of NT-proBNP in serum specimens collected in Becton Dickinson Vacutainer (SST) tubes. Clin Chem 2003, 49:958-960.
36. Narayanan S. The preanalytical phase - an important component of laboratory medicine. Am J Clin Pathol 2000, 113:429-452.
37. Biological Variation Database specifications - Westgard QC http://www.westgard.com/biodatabase1.htm.